CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Glaxo Group Limited v. Transpire Bio Inc.

0:25-cv-61939

Overview

Case Number 0:25-cv-61939
Filing Date 2025-09-25
Status Litigation filed
Court District Court, S.D. Florida (flsd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 15:1126 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Transpire Bio Inc. Operating Company

Represented By

14 Attorneys Listed

Tre'Ana Lynnae Thompson

Cole, Scott, Kissane, P.A.

Tel: +1 (561) 612-3419

Cole, Scott, Kissane, P.A., 222 Lakeview Ave.

Stephen Richard Auten

Taft Stettinius , Hollister

Tel: +1 (312) 840-4313

Taft Stettinius , Hollister, 111 East Wacker Drive

Rachel Smoot

Taft Stettinius & Hollister, LLP

Tel: +1 (614) 221-2838

41 S. High Street, Suite 1800, Columbus, IN 43215

Rachel S. Horn

Taft Stettinius & Hollister, LLP

Tel: +1 (513) 381-2838

301 E. 4th Street, Suite 2800, Cincinnati, OH 45202

Michael K. Nutter

Taft Stettinius & Hollister, LLP

Tel: +1 (312) 527-4000

111 E. Wacker Drive, Suite 2600, Chicago, IL 60601

Lorenz Michel Pruss

Kaplan Rothstein Pruss Peraza

Tel: +1 (305) 374-1920
Fax: +1 (305) 374-1961

Kaplan Rothstein Pruss Peraza, 2665 S Bayshore Drive PH2B

Karen McDaniel

Taft Stettinius & Hollister, LLP

Tel: +1 (612) 977-8400

80 South 8th Street,, 2200 IDS Center

Justin Matthew Kolnick

Cole Scott , Kissane

Tel: +1 (561) 612-3442
Fax: +1 (561) 683-8977

Cole Scott , Kissane, 222 Lakeview Avenue

Jaimin Hemendra Shah

Taft Stettinius & Hollister LLP

Tel: +1 (312) 527-4000

111 E. Wacker Drive, Suite 2600, Chicago, IL 60601

Briana D. Long

Taft Stettinius & Hollister, LLP

Tel: +1 (312) 840-4430

675 Fifteenth Street, Suite 2300, Denver, CO 80202

Ashley M. Bennett Ewald

Taft Stettinius & Hollister, LLP

Tel: +1 (612) 977-8400

80 South Eighth Street,, 2200 IDS Center

Alex M. Matthews

Taft Stettinius & Hollister LLP

Tel: +1 (317) 713-3500

One Indiana Square, Suite 3500, Indianapolis, IN 46204

Aaron M. Johnson

Taft Stettinius & Hollister, LLP

Tel: +1 (612) 977-8400

2200 IDS Center, 80 South Eighth St

Justin B. Levine

Cole, Scott and Kissane

Tel: +1 (561) 383-9200
Fax: +1 (561) 683-8977

Cole, Scott and Kissane, 222 Lakeview Avenue

Counter Defendant

GlaxoSmithKline Intellectual Property Development Limited NPE (University / Research)

Represented By

11 Attorneys Listed

Tammy Terry

Nelson Mullins Riley & Scarborough LLP

Tel: +1 (346) 646-6670

Heritage Plaza, 1111 Bagby Street, Suite 2100

Sharon K. Gagliardi

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Pejmon Pashai

Dechert LLP

Tel: +1 (202) 261-3300

1900 K Street, N.W., Washington, DC 20006

Martin J. Black

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Luke M. Reilly

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Kevin M. Flannery

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Judah Bellin

Dechert LLP

Tel: +1 (215) 994-2139

Cira Centre, 2929 Arch Street

Jennifer Insley-Pruitt

Dechert LLP

Tel: +1 (212) 698-3500

Three Bryant Park, 1095 Avenue of the Americas

Brian M. Goldberg

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Michael Tyler Woods

Nelson Mullins Riley & Scarborough LLP

Tel: +1 (305) 373-9426

2 Biscayne Blvd., 21st Floor

Mark Francis Raymond

Nelson Mullins Broad and Cassel

Tel: +1 (305) 373-9425

Nelson Mullins Broad and Cassel, 2 S Biscayne Boulevard

Glaxo Group Limited NPE (University / Research)

Represented By

11 Attorneys Listed

Tammy Terry

Nelson Mullins Riley & Scarborough LLP

Tel: +1 (346) 646-6670

Heritage Plaza, 1111 Bagby Street, Suite 2100

Sharon K. Gagliardi

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Pejmon Pashai

Dechert LLP

Tel: +1 (202) 261-3300

1900 K Street, N.W., Washington, DC 20006

Martin J. Black

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Luke M. Reilly

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Kevin M. Flannery

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Judah Bellin

Dechert LLP

Tel: +1 (215) 994-2139

Cira Centre, 2929 Arch Street

Jennifer Insley-Pruitt

Dechert LLP

Tel: +1 (212) 698-3500

Three Bryant Park, 1095 Avenue of the Americas

Brian M. Goldberg

Dechert LLP

Tel: +1 (215) 994-4000

Cira Centre, 2929 Arch Street

Michael Tyler Woods

Nelson Mullins Riley & Scarborough LLP

Tel: +1 (305) 373-9426

2 Biscayne Blvd., 21st Floor

Mark Francis Raymond

Nelson Mullins Broad and Cassel

Tel: +1 (305) 373-9425

Nelson Mullins Broad and Cassel, 2 S Biscayne Boulevard

Court & Judges

Court

District Court, S.D. Florida (flsd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8161968
Medicament dispenser
Filed: 2004-07-21
Issued: 2012-04-24
Active (1.2 yrs remaining) +1294d PTA
Expires: 2028-02-05

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1294 days) / Cellect Scrutiny — Over 1294 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

24

Dispositive

0

Granted

5

Denied

0

Pending / Review

11

Motions by Category

Procedural / Extension Motion 19 Motion to Compel Discovery 2 Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
Order on Motion for Extension of Time to File Response/Reply/Answer
Entry #— • 2026-08-05
Procedural / Extension Motion Pending
Order on Motion for Extension of Time
Entry #— • 2026-07-21
Procedural / Extension Motion Pending
Order on Motion for Extension of Time
Entry #— • 2026-07-14
Claim Construction / Markman Filing Pending / Under Review
MEMORANDUM of Law Opening Claim Construction/Markman Brief by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited. (Attachments: # 1 ...
Entry #109 • 2026-07-10 Document →
Claim Construction / Markman Filing Pending / Under Review
MEMORANDUM of Law re 109 Memorandum Opening Claim Construction Brief by Transpire Bio Inc.. (Attachments: # 1 Exhibit A - Declaration of Jaimin H. Shah, Esq., #...
Entry #110 • 2026-07-10 Document →
Claim Construction / Markman Filing Pending / Under Review
Statement of: Joint Claim Construction and Prehearing Statement by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited (Attachments: ...
Entry #106 • 2026-06-22 Document →

Docket Entries

(205 total)
Pleading / Complaint

COMPLAINT against TRANSPIRE BIO INC.. Filing fees $ 405.00 receipt number AFLSDC-18821013, filed by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O)(Raymond, Mark) (Entered: 09/25/2025)

Entry #1 • 2025-09-25
1
Pleading / Complaint

COMPLAINT against TRANSPIRE BIO INC.. Filing fees $ 405.00 receipt number AFLSDC-18821013, filed by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O)(Raymond, Mark) (Entered: 09/25/2025)

Entry #1 • 2025-09-25
2
Pleading / Complaint

COMPLAINT against TRANSPIRE BIO INC.. Filing fees $ 405.00 receipt number AFLSDC-18821013, filed by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O)(Raymond, Mark) (Entered: 09/25/2025)

Entry #1 • 2025-09-25
2
Pleading / Complaint

COMPLAINT against TRANSPIRE BIO INC.. Filing fees $ 405.00 receipt number AFLSDC-18821013, filed by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O)(Raymond, Mark) (Entered: 09/25/2025)

Entry #1 • 2025-09-25
2
Pleading / Complaint

COMPLAINT against TRANSPIRE BIO INC.. Filing fees $ 405.00 receipt number AFLSDC-18821013, filed by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O)(Raymond, Mark) (Entered: 09/25/2025)

Entry #1 • 2025-09-25
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc